FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $584,043 | -50.5% | 275,492 | +11.0% | 0.00% | – |
| Q2 2023 | $1,180,947 | +168.9% | 248,098 | +222.0% | 0.00% | – |
| Q1 2023 | $439,236 | +131.2% | 77,059 | +309.3% | 0.00% | – |
| Q4 2022 | $190,000 | -90.0% | 18,826 | -77.9% | 0.00% | -100.0% |
| Q3 2022 | $1,906,000 | -3.7% | 85,057 | +6.5% | 0.00% | 0.0% |
| Q2 2022 | $1,979,000 | -27.2% | 79,874 | +13.9% | 0.00% | 0.0% |
| Q1 2022 | $2,719,000 | -90.9% | 70,132 | -86.3% | 0.00% | -87.5% |
| Q4 2021 | $29,937,000 | -36.6% | 511,652 | -35.8% | 0.01% | -46.7% |
| Q3 2021 | $47,221,000 | -18.6% | 796,671 | +19.2% | 0.02% | -16.7% |
| Q2 2021 | $58,016,000 | +13.2% | 668,448 | +7.5% | 0.02% | +5.9% |
| Q1 2021 | $51,260,000 | +113.0% | 621,705 | +134.9% | 0.02% | +88.9% |
| Q4 2020 | $24,063,000 | +77.7% | 264,639 | -21.9% | 0.01% | +50.0% |
| Q3 2020 | $13,543,000 | +11.5% | 338,825 | -4.3% | 0.01% | +20.0% |
| Q2 2020 | $12,149,000 | +8.3% | 354,058 | -29.9% | 0.01% | -16.7% |
| Q1 2020 | $11,217,000 | -70.6% | 505,026 | -74.1% | 0.01% | -62.5% |
| Q4 2019 | $38,168,000 | +63.6% | 1,950,273 | +29.8% | 0.02% | +60.0% |
| Q3 2019 | $23,335,000 | +63.4% | 1,502,562 | +113.7% | 0.01% | +66.7% |
| Q2 2019 | $14,277,000 | +1556.3% | 703,276 | +695.9% | 0.01% | – |
| Q1 2018 | $862,000 | – | 88,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |